Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives

    NEXT STORY
    Matinas BioPharma to Present Positive Preclinical Data of MAT2203 at the 28th European Congress of Clinical Microbiology and Infectious Disease
    PREV STORY
    XORTX Announces PKD Foundation Collaboration
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Replimune Strengthens Executive Team with the Appointment of Jean Franchi as Chief Financial Officer

    author_avatar
    NASDAQ Market News

    Livestock Diagnostics Market Worth $1.85 billion by 2027- Exclusive Report by Meticulous Research®

    author_avatar
    NASDAQ Market News

    Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2

    author_avatar
    NASDAQ Market News